Aura Biosciences, Inc. (AURA)

Aura Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	31.69	41.06	121.58	149.06	17.39
Short-Term Investments	119.4	185.09	67.23	-	-
Cash & Short-Term Investments	151.09	226.15	188.81	149.06	17.39
Cash Growth	-33.19%	19.78%	26.66%	757.03%	-46.40%
Prepaid Expenses	1.7	1.82	2.17	2.73	0.05
Restricted Cash	-	0.02	0.02	0.02	0.02
Other Current Assets	7.83	3.81	5.7	1.88	0.99
Total Current Assets	160.62	231.79	196.7	153.7	18.46
Property, Plant & Equipment	20.59	22	26.04	6.2	3.57
Other Long-Term Assets	1.29	1.28	1.19	0.13	0.08
Total Assets	182.5	255.08	223.94	160.03	22.1
Accounts Payable	2.3	1.79	2.92	2.4	0.61
Accrued Expenses	8.84	6.95	4.25	3.83	1.77
Current Portion of Leases	3.15	2.69	2.96	0.62	-
Other Current Liabilities	0.62	0.94	0.33	0.51	0.28
Total Current Liabilities	14.91	12.36	10.46	7.36	2.66
Long-Term Leases	15.62	16.87	17.9	0.36	-
Other Long-Term Liabilities	-	-	-	-	0.08
Total Liabilities	30.53	29.23	28.35	7.72	2.74
Additional Paid-In Capital	525.93	512.62	406.56	304.45	8.17
Retained Earnings	-374.23	-287.31	-210.9	-152.14	-116.89
Comprehensive Income & Other	0.26	0.54	-0.07	-	-
Total Common Equity	151.97	225.85	195.58	152.32	-108.71
Shareholders' Equity	151.97	225.85	195.58	152.32	19.36
Total Liabilities & Equity	182.5	255.08	223.94	160.03	22.1
Total Debt	18.77	19.56	20.86	0.98	-
Net Cash (Debt)	132.33	206.59	167.95	148.09	17.39
Net Cash Growth	-35.95%	23.01%	13.41%	751.42%	-46.32%
Net Cash Per Share	2.67	5.21	5.61	28.70	47.37
Filing Date Shares Outstanding	50.23	49.5	37.8	29.22	0.44
Total Common Shares Outstanding	50	49.35	37.77	29.21	0.38
Working Capital	145.71	219.44	186.25	146.35	15.79
Book Value Per Share	3.04	4.58	5.18	5.21	-285.22
Tangible Book Value	151.97	225.85	195.58	152.32	-108.71
Tangible Book Value Per Share	3.04	4.58	5.18	5.21	-285.22
Machinery	8.46	7.8	7.43	5.64	4.77
Construction In Progress	0.27	0.39	1.81	2.37	1.15
Leasehold Improvements	0.47	-	-	0.01	-

Updated Mar 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q